NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Other Working Capital Changes (2015 - 2025)

NextPlat's (NXPL) quarterly Other Working Capital Changes came in at -$128000.0 in Q1 2026, down 236.84% year-over-year from $93538.5 in Q1 2025, and up 45.06% quarter-over-quarter from -$233000.0 in Q4 2025.

Analysis

NextPlat (NXPL) Other Working Capital Changes (2015 - 2025) Analysis & Trends

NextPlat (NXPL) has reported Other Working Capital Changes for 11 consecutive years, with -$128000.0 the latest figure, recorded in Q1 2026.

  • On a quarterly basis, Other Working Capital Changes fell 236.84% year-over-year to -$128000.0 in Q1 2026; TTM through Mar 2026 was -$612000.0, a 56.52% decrease from a year earlier, with the FY2025 full-year figure at -$522000.0, down 22.25% from the prior year.
  • Other Working Capital Changes was -$128000.0 for Q1 2026 at NextPlat, up from -$233000.0 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $229000.0 in Q3 2023 and troughed at -$245000.0 in Q4 2023.
  • A 5-year average of $8881.4 and a median of $1878.0 in 2022 frame the typical range for Other Working Capital Changes.
  • Across the five-year window, Other Working Capital Changes slumped 2723.73% in 2023 and jumped 95.65% in 2024, its largest moves.
  • Over 5 years, Other Working Capital Changes stood at -$39787.0 in 2022, then plunged by 616.31% to -$285000.0 in 2023, then surged by 47.37% to -$150000.0 in 2024, then tumbled by 55.33% to -$233000.0 in 2025, then jumped by 45.06% to -$128000.0 in 2026.
  • The last three Other Working Capital Changes figures came in at -$128000.0 (Q1 2026), -$233000.0 (Q4 2025), and -$99000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -50,000.00
Dec 31, 2025 -50,000.00
Sep 30, 2025 168,000.00
Sep 30, 2025 168,000.00
Jun 30, 2025 -64,000.00
Jun 30, 2025 -64,000.00
Mar 31, 2025 50,000.00
Mar 31, 2025 50,000.00
Dec 31, 2024 -15,000.00
Dec 31, 2024 -15,000.00
Sep 30, 2024 -38,000.00
Sep 30, 2024 -38,000.00
Jun 30, 2024 2,000.00
Jun 30, 2024 2,000.00
Mar 31, 2024 98,000.00
Mar 31, 2024 98,000.00
Dec 31, 2023 -245,000.00
Dec 31, 2023 -245,000.00
Sep 30, 2023 229,000.00
Sep 30, 2023 229,000.00